Autopsy report · NCT02184130

Altered Vestibular Perception and Transcranial Magnetic Stimulation

“insufficient funds and participants, thus terminated”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 9 months after it had already started.
• Ran for about 5 years 11 months before it stopped.
• 7 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University of Zurich

Sponsor type

University, hospital or other

Conditions

Verticality Perception; Self-motion Perception

Interventions

transcranial magnetic stimulation and motion stimuli

Participants

7

Sites

1

Countries

Switzerland

Trials that died the same way

• Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
  “Terminated due to insufficient funding” (75% match in meaning)
• IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery
  “Terminated due to lack of funding” (70% match in meaning)
• Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique
  “insufficient funds” (68% match in meaning)
• Long Term Follow up of Subjects Exposed to Genetically Engineered T Cell Receptors
  “terminated after participants were enrolled” (68% match in meaning)
• The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations
  “Funding was terminated” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.